MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Avadel Pharmaceuticals plc P/E 2011-2026 | AVDL
P/E Jährlich Avadel Pharmaceuticals plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.7 | -6.4 | -4.08 | -6.1 | 55 | -8.21 | -1.08 | 6.52 | -9.14 | 10.1 | -6.14 | -6.42 | -32 | -17.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 55 | -32 | -2.87 |
P/E anderer Aktien in der Arzneimittelhersteller
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-1.71 | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
-5.04 | - | - | $ 142 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-4.35 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.0895 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.679 | - | 0.86 % | $ 117 M | USA |
 |
Aurora Cannabis
ACB
|
-1.32 | $ 3.29 | -0.6 % | $ 86.3 M |  Canada |
 |
China Pharma Holdings
CPHI
|
-0.959 | $ 0.63 | 0.3 % | $ 11 M |  China |
 |
Catalent
CTLT
|
-10.4 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
-0.111 | - | -23.39 % | $ 1.76 M | USA |
 |
Cronos Group
CRON
|
-49.6 | $ 2.51 | -0.33 % | $ 1.31 B | Canada |
 |
DURECT Corporation
DRRX
|
-1.15 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
-0.182 | $ 7.98 | -0.87 % | $ 409 M | USA |
 |
Endo International plc
ENDP
|
-0.0278 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.287 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-1.9 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-0.775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-46.5 | $ 3.05 | - | $ 42.9 M | USA |
 |
Bausch Health Companies
BHC
|
-5.71 | $ 4.99 | -2.35 % | $ 1.82 B | Canada |
 |
Harrow Health
HROW
|
-376 | $ 34.02 | 0.05 % | $ 1.25 B | USA |
 |
OptiNose
OPTN
|
-5.4 | - | - | $ 1.08 B | USA |
 |
Evolus
EOLS
|
-5.26 | $ 4.54 | -3.1 % | $ 293 M | USA |
 |
Pacira BioSciences
PCRX
|
-11.8 | $ 22.49 | -0.71 % | $ 1.04 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
9.54 | - | -39.89 % | $ 27.7 M | USA |
 |
Relmada Therapeutics
RLMD
|
-4.3 | $ 5.8 | -1.02 % | $ 229 M | USA |
 |
Rockwell Medical
RMTI
|
-4.2 | $ 1.03 | 0.98 % | $ 24 M | USA |
 |
Assertio Holdings
ASRT
|
-2.48 | $ 14.91 | 6.5 % | $ 95.5 M | USA |
 |
Canopy Growth Corporation
CGC
|
-0.237 | $ 0.95 | -2.29 % | $ 102 M | Canada |
 |
Solid Biosciences
SLDB
|
-3.57 | $ 6.87 | -3.78 % | $ 601 M | USA |
 |
OrganiGram Holdings
OGI
|
-2.92 | $ 1.35 | -0.74 % | $ 402 M | Canada |
 |
PetIQ
PETQ
|
186 | - | 1.64 % | $ 400 M | USA |
 |
Sundial Growers
SNDL
|
-0.00386 | $ 1.35 | -1.1 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-1.06 | $ 2.42 | -5.1 % | $ 3 M | USA |
 |
PLx Pharma
PLXP
|
-2.56 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
7.07 | - | - | $ 5.07 M | USA |
 |
Jupiter Wellness
JUPW
|
-1.67 | - | - | $ 33.6 M | USA |
 |
Radius Health
RDUS
|
-5.38 | - | - | $ 1.42 B | USA |
 |
Lannett Company
LCI
|
-0.108 | - | 1.15 % | $ 7.11 M | USA |
 |
Tilray
TLRY
|
-0.821 | $ 6.41 | -0.7 % | $ 3.96 B | Canada |
 |
SCYNEXIS
SCYX
|
-4.41 | $ 0.9 | 3.23 % | $ 44.9 M | USA |
 |
TherapeuticsMD
TXMD
|
-2.33 | $ 2.31 | - | $ 24.1 M | USA |
 |
Veru
VERU
|
-2.85 | $ 2.29 | -0.43 % | $ 309 M | USA |
 |
Viatris
VTRS
|
336 | $ 13.2 | -0.68 % | $ 15.8 B | USA |
 |
Organogenesis Holdings
ORGO
|
482 | $ 2.42 | -2.23 % | $ 319 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.126 | - | - | $ 193 M | Canada |
 |
Perrigo Company plc
PRGO
|
-1.38 | $ 9.43 | -1.46 % | $ 1.31 B | USA |
 |
cbdMD
YCBD
|
-11 | $ 0.76 | -1.19 % | $ 3.28 M | USA |
 |
Recro Pharma
REPH
|
-10 | - | -4.76 % | $ 65.3 M | USA |
 |
Tricida
TCDA
|
-2.03 | - | - | $ 3.25 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.536 | - | - | $ 55.5 M | USA |